Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grubbs

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|November 7, 2009
Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancersVernon E Steele, Chinthalapally V Rao, Yuting Zhang, et al.
The Journal of Surgical Research|June 17, 2018
A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitroAdele P Williams, Alicia M Waters, Jerry E Stewart, et al.
Molecular Carcinogenesis|February 24, 1999
A comparative analysis of allelic imbalance events in chemically induced rat mammary, colon, and bladder tumorsJ D Haag, G M Brasic, L A Shepel, et al.
Journal of Medicinal Chemistry|August 9, 2003
Conformationally defined retinoic acid analogues. 5. Large-scale synthesis and mammary cancer chemopreventive activity for (2E,4E,6Z,8E)-8-(3',4'-dihydro-1'(2'H)-naphthalen-1'-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acid (9cUAB30)Venkatram R Atigadda, Kimberly K Vines, Clinton J Grubbs, et al.
Oncology Reports|March 4, 2011
Efficacy of the EGFr inhibitor Iressa on development of chemically-induced urinary bladder cancers: dose dependency and modulation of biomarkersRonald A Lubet, Yan Lu, Ann M Bode, et al.
Cancer Research|March 1, 1981
Inhibition of urinary bladder cancer by N-(ethyl)-all-trans-retinamide and N-(2-hydroxyethyl)-all-trans-retinamide in rats and miceH J Thompson, P J Becci, C J Grubbs, et al.
Anticancer Research|January 1, 1993
Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumorsC J Grubbs, M M Juliana, I Eto, et al.
Science (New York, N.Y.)|November 18, 1977
13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamineC J Grubbs, R C Moon, R A Squire, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 13, 2015
Prevention of chemically induced urinary bladder cancers by naproxen: protocols to reduce gastric toxicity in humans do not alter preventive efficacyRonald A Lubet, James M Scheiman, Ann Bode, et al.
Oncogene|March 8, 2005
Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancerLaundette P Jones, Minglin Li, Ewa D Halama, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
Cancer Prevention Research (Philadelphia, Pa.)|November 7, 2009
Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancersVernon E Steele, Chinthalapally V Rao, Yuting Zhang, et al.
The Journal of Surgical Research|June 17, 2018
A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitroAdele P Williams, Alicia M Waters, Jerry E Stewart, et al.
Molecular Carcinogenesis|February 24, 1999
A comparative analysis of allelic imbalance events in chemically induced rat mammary, colon, and bladder tumorsJ D Haag, G M Brasic, L A Shepel, et al.
Journal of Medicinal Chemistry|August 9, 2003
Conformationally defined retinoic acid analogues. 5. Large-scale synthesis and mammary cancer chemopreventive activity for (2E,4E,6Z,8E)-8-(3',4'-dihydro-1'(2'H)-naphthalen-1'-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acid (9cUAB30)Venkatram R Atigadda, Kimberly K Vines, Clinton J Grubbs, et al.
Oncology Reports|March 4, 2011
Efficacy of the EGFr inhibitor Iressa on development of chemically-induced urinary bladder cancers: dose dependency and modulation of biomarkersRonald A Lubet, Yan Lu, Ann M Bode, et al.
Cancer Research|March 1, 1981
Inhibition of urinary bladder cancer by N-(ethyl)-all-trans-retinamide and N-(2-hydroxyethyl)-all-trans-retinamide in rats and miceH J Thompson, P J Becci, C J Grubbs, et al.
Anticancer Research|January 1, 1993
Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumorsC J Grubbs, M M Juliana, I Eto, et al.
Science (New York, N.Y.)|November 18, 1977
13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamineC J Grubbs, R C Moon, R A Squire, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 13, 2015
Prevention of chemically induced urinary bladder cancers by naproxen: protocols to reduce gastric toxicity in humans do not alter preventive efficacyRonald A Lubet, James M Scheiman, Ann Bode, et al.
Oncogene|March 8, 2005
Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancerLaundette P Jones, Minglin Li, Ewa D Halama, et al.
Pageof 16